Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Coghlan

Showing results (321-330 of 338) with videos related to

Pageof 34
Sort By:
The Journal of Endocrinology|May 1, 1979
Control of aldosterone secretionJ P Coghlan, J R Blair-West, D A Denton, et al.
Kidney International|October 1, 1973
Studies on the metabolism of aldosterone in chronic renal failure and anephric manG H Williams, G L Bailey, C L Hampers, et al.
Diabetes|August 24, 2021
Genetically Predicted Glucose-Dependent Insulinotropic Polypeptide (GIP) Levels and Cardiovascular Disease Risk Are Driven by Distinct Causal Variants in the <i>GIPR</i> RegionNicholas Bowker, Robert Hansford, Stephen Burgess, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 12, 2020
Structural basis for GLP-1 receptor activation by LY3502970, an orally active nonpeptide agonistTakahiro Kawai, Bingfa Sun, Hitoshi Yoshino, et al.
Metabolism: Clinical and Experimental|September 18, 2004
Development of glucose intolerance in male transgenic mice overexpressing human glycogen synthase kinase-3beta on a muscle-specific promoterNigel J Pearce, Jonathan R S Arch, John C Clapham, et al.
Diabetes, Obesity & Metabolism|July 6, 2016
Robust anti-obesity and metabolic effects of a dual GLP-1/glucagon receptor peptide agonist in rodents and non-human primatesS J Henderson, A Konkar, D C Hornigold, et al.
Chemistry & Biology|October 18, 2000
Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcriptionM P Coghlan, A A Culbert, D A Cross, et al.
Diabetes, Obesity & Metabolism|January 9, 2026
GLP-1R biased cAMP agonism maintains glycemic control with reduced malaise and emesis in preclinical mammalian modelsCaitlin Baumer-Harrison, Danya Aldaghma, Alex D White, et al.
JCI Insight|July 31, 2020
Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonistFrancis S Willard, Jonathan D Douros, Maria Bn Gabe, et al.
Cell Metabolism|December 6, 2024
The GIP receptor activates futile calcium cycling in white adipose tissue to increase energy expenditure and drive weight loss in miceXinxin Yu, Shiuhwei Chen, Jan-Bernd Funcke, et al.
Pageof 34

Showing results (321-330 of 338) with videos related to

Sort By:
Pageof 34
The Journal of Endocrinology|May 1, 1979
Control of aldosterone secretionJ P Coghlan, J R Blair-West, D A Denton, et al.
Kidney International|October 1, 1973
Studies on the metabolism of aldosterone in chronic renal failure and anephric manG H Williams, G L Bailey, C L Hampers, et al.
Diabetes|August 24, 2021
Genetically Predicted Glucose-Dependent Insulinotropic Polypeptide (GIP) Levels and Cardiovascular Disease Risk Are Driven by Distinct Causal Variants in the <i>GIPR</i> RegionNicholas Bowker, Robert Hansford, Stephen Burgess, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 12, 2020
Structural basis for GLP-1 receptor activation by LY3502970, an orally active nonpeptide agonistTakahiro Kawai, Bingfa Sun, Hitoshi Yoshino, et al.
Metabolism: Clinical and Experimental|September 18, 2004
Development of glucose intolerance in male transgenic mice overexpressing human glycogen synthase kinase-3beta on a muscle-specific promoterNigel J Pearce, Jonathan R S Arch, John C Clapham, et al.
Diabetes, Obesity & Metabolism|July 6, 2016
Robust anti-obesity and metabolic effects of a dual GLP-1/glucagon receptor peptide agonist in rodents and non-human primatesS J Henderson, A Konkar, D C Hornigold, et al.
Chemistry & Biology|October 18, 2000
Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcriptionM P Coghlan, A A Culbert, D A Cross, et al.
Diabetes, Obesity & Metabolism|January 9, 2026
GLP-1R biased cAMP agonism maintains glycemic control with reduced malaise and emesis in preclinical mammalian modelsCaitlin Baumer-Harrison, Danya Aldaghma, Alex D White, et al.
JCI Insight|July 31, 2020
Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonistFrancis S Willard, Jonathan D Douros, Maria Bn Gabe, et al.
Cell Metabolism|December 6, 2024
The GIP receptor activates futile calcium cycling in white adipose tissue to increase energy expenditure and drive weight loss in miceXinxin Yu, Shiuhwei Chen, Jan-Bernd Funcke, et al.
Pageof 34